Background: Male osteoporosis is now a well-recognized medical disorder with established clinical guidelines for both diagnosis and management. Prevention as well as management of osteoporosis in men consulting the andro- logical outpatient clinic because of low testosterone, how- ever, is not well established. This gap of knowledge is -at least partly- explained by the controversy with respect to the threshold of testosterone needed for skeletal mainte- nance. However, testosterone deficiency may be clearly associated with bone loss as well frailty in men. The aim of the guideline was to provide andrologists with the most updated, evidence based advices on the management of bone disease in men and to make them aware of the potential silent presence of osteoporosis in hypogonadal men. Methods: The GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) system for grading the quality of evidence and the strength of recom- mendations was used to grade recommendations. Results: A total of 32 recommendations were provided concerning clinical evaluation, diagnosis and therapy of male osteoporosis in the andrological patient. Conclusion: Therefore, the management of patients with potential hypogonadism should include a complete bone health assessment, besides clinical and biochemical evalu- ation of gonadal status. Such bone health assessment should include specific items in medical history and phys- ical examination related to fracture risk. Furthermore, dual-energy absorptiometry is indicated to evaluate frac- ture risk in men with confirmed clinical hypogonadism. Regarding treatment, besides general measures to prevent or manage male osteoporosis testosterone replacement can be initiated (as described in guidelines for hypogo- nadism), but data on its efficacy in preventing fractures are lacking. Thus, additional anti-osteoporotic may be needed, especially in men with very low testosterone who are at high risk for bone loss and/or in men not able to receive testosterone replacement.

EAA clinical guideline on management of bone health in the andrological outpatient clinic / Rochira, V.; Antonio, L.; Vanderschueren, D.. - In: ANDROLOGY. - ISSN 2047-2919. - 6:Suppl. 2(2018), pp. 272-285. [10.1111/andr.12470]

EAA clinical guideline on management of bone health in the andrological outpatient clinic

V. Rochira;
2018

Abstract

Background: Male osteoporosis is now a well-recognized medical disorder with established clinical guidelines for both diagnosis and management. Prevention as well as management of osteoporosis in men consulting the andro- logical outpatient clinic because of low testosterone, how- ever, is not well established. This gap of knowledge is -at least partly- explained by the controversy with respect to the threshold of testosterone needed for skeletal mainte- nance. However, testosterone deficiency may be clearly associated with bone loss as well frailty in men. The aim of the guideline was to provide andrologists with the most updated, evidence based advices on the management of bone disease in men and to make them aware of the potential silent presence of osteoporosis in hypogonadal men. Methods: The GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) system for grading the quality of evidence and the strength of recom- mendations was used to grade recommendations. Results: A total of 32 recommendations were provided concerning clinical evaluation, diagnosis and therapy of male osteoporosis in the andrological patient. Conclusion: Therefore, the management of patients with potential hypogonadism should include a complete bone health assessment, besides clinical and biochemical evalu- ation of gonadal status. Such bone health assessment should include specific items in medical history and phys- ical examination related to fracture risk. Furthermore, dual-energy absorptiometry is indicated to evaluate frac- ture risk in men with confirmed clinical hypogonadism. Regarding treatment, besides general measures to prevent or manage male osteoporosis testosterone replacement can be initiated (as described in guidelines for hypogo- nadism), but data on its efficacy in preventing fractures are lacking. Thus, additional anti-osteoporotic may be needed, especially in men with very low testosterone who are at high risk for bone loss and/or in men not able to receive testosterone replacement.
2-mar-2018
6
Suppl. 2
272
285
EAA clinical guideline on management of bone health in the andrological outpatient clinic / Rochira, V.; Antonio, L.; Vanderschueren, D.. - In: ANDROLOGY. - ISSN 2047-2919. - 6:Suppl. 2(2018), pp. 272-285. [10.1111/andr.12470]
Rochira, V.; Antonio, L.; Vanderschueren, D.
File in questo prodotto:
File Dimensione Formato  
081_Rochira_et_al_Andrology_2018.pdf

accesso aperto

Descrizione: Full text of the article
Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 265.71 kB
Formato Adobe PDF
265.71 kB Adobe PDF Visualizza/Apri
081_Rochira_et_al_Andrology_2018_with_solicited_article_invitation.pdf

accesso aperto

Descrizione: Full text of the article + Letter of invitation for a solicited review article
Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 316.63 kB
Formato Adobe PDF
316.63 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1168962
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 37
social impact